Tuesday, March 10, 2020

(Reuters Health) - A cheaper HIV prevention pill is going on sale soon in the U.S., but the price drop won't help as many people if doctors instead prescribe a newer, more expensive brand-name drug, experts say.


from Reuters: Health News https://ift.tt/2TONa9T

Related Posts:

  • LATEST HEALTH NEWS(Reuters) - Japanese drugmaker Eisai Co and Biogen Inc said that the final analysis of a mid-stage trial of their Alzheimer's drug showed positive results for patients who received the highest dose. from Reuters: Health … Read More
  • LATEST HEALTH NEWSNEW YORK (Reuters) - In the escalating battle over U.S. prescription drug prices, major pharmaceutical companies are scrambling to limit the economic damage from a new U.S. insurer tactic that coaxes patients away from expens… Read More
  • LATEST HEALTH NEWSLONDON (Reuters) - AstraZeneca suffered its biggest daily share price drop a year ago after a key cancer drug trial failed amid feverish speculation the chief executive might quit. from Reuters: Health News https://ift.t… Read More
  • LATEST HEALTH NEWSWASHINGTON (Reuters) - A U.S. private citizen who visited China has reported symptoms like those of U.S. diplomats afflicted with a mysterious illness in Havana and Guangzhou, a U.S. State Department official said on Thursday… Read More
  • LATEST HEALTH NEWSWASHINGTON (Reuters) - Two buildings at the Johns Hopkins Hospital in Baltimore, Maryland, were evacuated on Thursday because people may have been exposed to tuberculosis, a hospital spokeswoman said. from Reuters: Healt… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner